Position in CRBU
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$108,153
-$10,414 QoQ
Shares Held
56,923
-23.7% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 137 holders
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRBU Over Time
Shares Held
Position Value (USD)
Derivatives in CRBU
reported options exposure · as of Sep 30, 2024CallValue
$9,604
CallShares
4,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,428,056,604 across 399 Biotechnology names. CRBU ranks #203 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in CRBU
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $108,153 | 56,923 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $118,567 | 74,571 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,660 | 1,571 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $39,514 | 31,361 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $58,356 | 63,919 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $120,481 | 75,775 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $139,893 | 71,375 | Shares | Defined | 2024-11-12 | |
| 2024-09-30 | $9,604 | 4,900 | Call | Defined | 2024-11-12 | |
| 2024-06-30 | $86,248 | 52,591 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $2,413,331 | 469,520 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $926,649 | 161,719 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,057,173 | 221,166 | Shares | Defined | 2023-12-06 | |
| 2023-06-30 | $111,987 | 26,350 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $1,039,140 | 195,695 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $647,518 | 103,108 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,356,983 | 128,624 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $76,155 | 14,025 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $206,449 | 22,489 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $460,184 | 30,496 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $53,110 | 2,225 | Shares | Defined | 2021-11-10 | |
| No filing history on record for this holder in this stock. | ||||||